Herpes Simplex Virus: Clinical Overview and qPCR Detection

Herpes simplex viruses belong to the family Herpesviridae and are enveloped double-stranded DNA viruses. The two main human types are HSV-1 and HSV-2. Both share similar structural features and biological behavior, including the ability to establish lifelong latency in sensory nerve ganglia after primary infection.

HSV alternates between latent and active states. During latency, the viral genome persists in nerve cells without producing overt disease. Reactivation may occur periodically and can be triggered by factors such as fever, illness, ultraviolet light exposure, emotional stress, menstruation, trauma, or surgery. Reactivated virus then travels to epithelial surfaces, where it may produce recurrent lesions or asymptomatic viral shedding.

Although HSV-1 is most commonly associated with oral infection and HSV-2 with genital infection, both types can infect oral or genital sites depending on the route of exposure. This overlapping tropism is important for diagnosis and epidemiological interpretation.

HSV is transmitted primarily through direct skin-to-skin or mucosal contact. HSV-1 is most often spread through oral contact with saliva, oral lesions, or infected skin surfaces around the mouth, while HSV-2 is mainly transmitted through sexual contact involving genital or anal mucosa, lesions, or secretions.

Transmission may occur when lesions are present, but viral shedding can also occur from clinically normal-appearing skin or mucosa. As a result, many individuals unknowingly transmit infection. HSV-1 may also be transmitted to the genital area through oral-genital contact, leading to genital herpes.

In rare cases, HSV can be transmitted from mother to infant during delivery, causing neonatal herpes. The risk is highest when maternal primary infection occurs late in pregnancy. Because asymptomatic infection is common, laboratory confirmation is especially important in risk assessment and clinical management.

Many HSV infections are asymptomatic or clinically unrecognized. When symptoms occur, they typically include painful blisters or ulcers that may recur over time. Primary infection is often more symptomatic than recurrent episodes and may be accompanied by fever, body aches, headache, sore throat, and regional lymphadenopathy.

Oral herpes commonly presents with cold sores or ulcerative lesions in or around the lips and mouth. Genital herpes may present with papules, vesicles, erosions, or ulcers involving the genital or anal region. Lesions may rupture, ooze, and crust over before healing.

Recurrent episodes are generally shorter and milder than the initial outbreak, but they may still cause significant discomfort and psychosocial burden. HSV-2 infection is more likely than genital HSV-1 infection to cause recurrent genital symptoms. In immunocompromised individuals, disease may be more severe, prolonged, or disseminated. Rare but important complications include encephalitis, keratitis, meningoencephalitis, and neonatal herpes.

HSV-2 infection is also clinically important because it increases the risk of acquiring and transmitting HIV infection. For this reason, genital herpes has implications beyond local lesion disease and remains highly relevant in sexual health and public health programs.

Laboratory diagnosis of HSV infection can be supported by clinical presentation, but confirmatory testing is often necessary because lesions may resemble those caused by other viral, bacterial, or inflammatory conditions. Molecular methods are especially useful for detecting viral DNA in lesion swabs, mucosal samples, and selected clinical specimens.

Probe-based quantitative PCR is a highly sensitive and specific method for HSV detection and differentiation. Type-specific qPCR assays can distinguish HSV-1 from HSV-2, which is clinically important because viral type influences recurrence patterns, transmission counseling, and epidemiological interpretation.

Molecular detection is particularly valuable in cases of atypical lesions, recurrent disease, neonatal risk assessment, immunocompromised patients, and research workflows requiring precise viral identification. Compared with symptom-based diagnosis alone, qPCR provides faster and more reliable confirmation of infection.

HSV infection is treatable but not curable. Antiviral agents such as acyclovir, valacyclovir, and famciclovir are commonly used to shorten symptom duration and reduce severity during first or recurrent episodes. Treatment is generally most effective when started early after symptom onset.

For patients with frequent or severe recurrences, daily suppressive therapy may reduce outbreak frequency and lower transmission risk to partners. Pain management may include systemic analgesics and topical anesthetic agents when appropriate. Supportive measures such as maintaining hydration, reducing irritation of lesions, and avoiding recognized triggers may also improve patient comfort.

Preventive counseling remains essential. Individuals with active lesions should avoid direct contact that could spread infection, including oral contact or sexual activity depending on lesion location. Condom use reduces but does not eliminate the risk of genital HSV transmission. Pregnant individuals with genital herpes symptoms should receive clinical evaluation because neonatal transmission is a serious complication.